Pharma giant Merck said it will spend $41 million at its Merck Serono facility in Bari, Italy, to build a new injectables production line.
The FDA is concerned that disruption of drug manufacturing in Puerto Rico could lead to critical shortages of some medicines.
Clinical care experts and patient advocacy organizations call attention to why better patient understanding shapes the best integrated approach to orphan drug…
AmerisourceBergen has pled guilty and agreed to pay $260 million to settle a federal case over its sales of cancer meds from an unregistered facility.
Generic API maker Cambrex said it will begin a $3.5 million project to improve wastewater processing capabilities at its facility in Sweden.
Brought to you by the publisher of FierceBiotech and FiercePharma, the Fierce Innovation Awards Life Sciences Edition identify and showcase outstanding…
ADC Biotechnology, a Welsh company specializing in antibody-drug conjugate contract services, said it will invest $11 million to build a new facility in…
As Puerto Rico struggles in the wake of Hurricane Maria last week, the pharmaceutical manufacturing industry on the island is effectively shut down.
GlaxoSmithKline has a deal to sell a consumer health products plant in the U.S. to CDMO Avara Pharmaceutical Services.
Fresenius Kabi, which has been spending heavily to broaden its capabilities, has started construction on a $250 million project in Illinois.
Roche has struck a deal to unload a plant in Spain to Recipharm, a move that will save 200 jobs as it sheds unneeded small-molecule facilities.
Zydus Cadila, an Indian injectables maker, said it reached a deal with Russia’s Pharm Aid to manufacture its varicella vaccine for the Russian Federation.